|
|
Volumn 15, Issue 4, 1999, Pages 787-792
|
|
Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
7-ETHYL-10-HYDROXYCAMPTOTHECIN;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CISPLATIN;
DEOXYCYTIDINE;
DNA TOPOISOMERASE;
DOCETAXEL;
DRUG DERIVATIVE;
GEMCITABINE;
PACLITAXEL;
TAXOID;
TOPOTECAN;
ADENOCARCINOMA;
ARTICLE;
CELL CULTURE;
CELL DIVISION;
CELL SURVIVAL;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG SCREENING;
HUMAN;
IC 50;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METABOLISM;
PATHOLOGY;
SENSITIVITY AND SPECIFICITY;
SQUAMOUS CELL CARCINOMA;
ADENOCARCINOMA;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CELL DIVISION;
CELL SURVIVAL;
CISPLATIN;
DEOXYCYTIDINE;
DNA TOPOISOMERASES, TYPE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
INHIBITORY CONCENTRATION 50;
LUNG NEOPLASMS;
PACLITAXEL;
SENSITIVITY AND SPECIFICITY;
TAXOIDS;
TOPOTECAN;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
|
EID: 0033209793
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.15.4.787 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
